nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0726	0.332	CbGbCtD
Tiagabine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0675	0.308	CbGbCtD
Tiagabine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.031	0.142	CbGbCtD
Tiagabine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0284	0.13	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0194	0.0885	CbGbCtD
Tiagabine—SLC6A1—ganglion—peripheral nervous system neoplasm	0.0128	0.467	CbGeAlD
Tiagabine—SLC6A1—trigeminal ganglion—peripheral nervous system neoplasm	0.0063	0.23	CbGeAlD
Tiagabine—SLC6A1—brainstem—peripheral nervous system neoplasm	0.00558	0.203	CbGeAlD
Tiagabine—SLC6A1—cerebellum—peripheral nervous system neoplasm	0.00275	0.1	CbGeAlD
Tiagabine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.000433	CcSEcCtD
Tiagabine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000326	0.000433	CcSEcCtD
Tiagabine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00043	CcSEcCtD
Tiagabine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00043	CcSEcCtD
Tiagabine—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000324	0.00043	CcSEcCtD
Tiagabine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000428	CcSEcCtD
Tiagabine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000322	0.000428	CcSEcCtD
Tiagabine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000322	0.000427	CcSEcCtD
Tiagabine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000321	0.000426	CcSEcCtD
Tiagabine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000321	0.000426	CcSEcCtD
Tiagabine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000321	0.000426	CcSEcCtD
Tiagabine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000425	CcSEcCtD
Tiagabine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00032	0.000425	CcSEcCtD
Tiagabine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000422	CcSEcCtD
Tiagabine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000318	0.000422	CcSEcCtD
Tiagabine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000421	CcSEcCtD
Tiagabine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000419	CcSEcCtD
Tiagabine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000419	CcSEcCtD
Tiagabine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000314	0.000416	CcSEcCtD
Tiagabine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000312	0.000414	CcSEcCtD
Tiagabine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000312	0.000414	CcSEcCtD
Tiagabine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000311	0.000413	CcSEcCtD
Tiagabine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000412	CcSEcCtD
Tiagabine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000307	0.000408	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000408	CcSEcCtD
Tiagabine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000307	0.000407	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000406	CcSEcCtD
Tiagabine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000402	CcSEcCtD
Tiagabine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.000401	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000398	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000398	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000398	CcSEcCtD
Tiagabine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000398	CcSEcCtD
Tiagabine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000299	0.000397	CcSEcCtD
Tiagabine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000298	0.000396	CcSEcCtD
Tiagabine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000393	CcSEcCtD
Tiagabine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000296	0.000393	CcSEcCtD
Tiagabine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000295	0.000392	CcSEcCtD
Tiagabine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000392	CcSEcCtD
Tiagabine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000389	CcSEcCtD
Tiagabine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000293	0.000389	CcSEcCtD
Tiagabine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000293	0.000388	CcSEcCtD
Tiagabine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000292	0.000388	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000388	CcSEcCtD
Tiagabine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000291	0.000387	CcSEcCtD
Tiagabine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000386	CcSEcCtD
Tiagabine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000289	0.000383	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000383	CcSEcCtD
Tiagabine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.000383	CcSEcCtD
Tiagabine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000287	0.00038	CcSEcCtD
Tiagabine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000286	0.000379	CcSEcCtD
Tiagabine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000377	CcSEcCtD
Tiagabine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000284	0.000377	CcSEcCtD
Tiagabine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000284	0.000376	CcSEcCtD
Tiagabine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000376	CcSEcCtD
Tiagabine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000374	CcSEcCtD
Tiagabine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Tiagabine—Pain—Etoposide—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Tiagabine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Tiagabine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000373	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000372	CcSEcCtD
Tiagabine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000279	0.00037	CcSEcCtD
Tiagabine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000278	0.000369	CcSEcCtD
Tiagabine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000368	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000368	CcSEcCtD
Tiagabine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000366	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000363	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000362	CcSEcCtD
Tiagabine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000362	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.00036	CcSEcCtD
Tiagabine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.00036	CcSEcCtD
Tiagabine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000271	0.00036	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000359	CcSEcCtD
Tiagabine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00027	0.000358	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000357	CcSEcCtD
Tiagabine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000269	0.000357	CcSEcCtD
Tiagabine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000269	0.000356	CcSEcCtD
Tiagabine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000356	CcSEcCtD
Tiagabine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.000353	CcSEcCtD
Tiagabine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000266	0.000352	CcSEcCtD
Tiagabine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000351	CcSEcCtD
Tiagabine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00035	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000349	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000348	CcSEcCtD
Tiagabine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000261	0.000347	CcSEcCtD
Tiagabine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000261	0.000346	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000346	CcSEcCtD
Tiagabine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Tiagabine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Tiagabine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000345	CcSEcCtD
Tiagabine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000344	CcSEcCtD
Tiagabine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000343	CcSEcCtD
Tiagabine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000258	0.000343	CcSEcCtD
Tiagabine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.000342	CcSEcCtD
Tiagabine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000342	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.00034	CcSEcCtD
Tiagabine—Rash—Vincristine—peripheral nervous system neoplasm	0.000256	0.00034	CcSEcCtD
Tiagabine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000256	0.000339	CcSEcCtD
Tiagabine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000256	0.000339	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000338	CcSEcCtD
Tiagabine—Headache—Vincristine—peripheral nervous system neoplasm	0.000254	0.000338	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000335	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000333	CcSEcCtD
Tiagabine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.000332	CcSEcCtD
Tiagabine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00025	0.000332	CcSEcCtD
Tiagabine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000246	0.000326	CcSEcCtD
Tiagabine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000242	0.000322	CcSEcCtD
Tiagabine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000321	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.00032	CcSEcCtD
Tiagabine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000241	0.00032	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000319	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000319	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000317	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000238	0.000316	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000314	CcSEcCtD
Tiagabine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000236	0.000313	CcSEcCtD
Tiagabine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000309	CcSEcCtD
Tiagabine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000233	0.000309	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000307	CcSEcCtD
Tiagabine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000304	CcSEcCtD
Tiagabine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000303	CcSEcCtD
Tiagabine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000226	0.0003	CcSEcCtD
Tiagabine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000226	0.0003	CcSEcCtD
Tiagabine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000225	0.000299	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000297	CcSEcCtD
Tiagabine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000295	CcSEcCtD
Tiagabine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000294	CcSEcCtD
Tiagabine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000294	CcSEcCtD
Tiagabine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000291	CcSEcCtD
Tiagabine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000219	0.00029	CcSEcCtD
Tiagabine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000218	0.000289	CcSEcCtD
Tiagabine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000288	CcSEcCtD
Tiagabine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000286	CcSEcCtD
Tiagabine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000213	0.000283	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000282	CcSEcCtD
Tiagabine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000278	CcSEcCtD
Tiagabine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000209	0.000278	CcSEcCtD
Tiagabine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000277	CcSEcCtD
Tiagabine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000276	CcSEcCtD
Tiagabine—Rash—Etoposide—peripheral nervous system neoplasm	0.000207	0.000275	CcSEcCtD
Tiagabine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000207	0.000275	CcSEcCtD
Tiagabine—Headache—Etoposide—peripheral nervous system neoplasm	0.000206	0.000273	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000273	CcSEcCtD
Tiagabine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000272	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000272	CcSEcCtD
Tiagabine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000204	0.00027	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000269	CcSEcCtD
Tiagabine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000269	CcSEcCtD
Tiagabine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000269	CcSEcCtD
Tiagabine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000268	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000268	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000267	CcSEcCtD
Tiagabine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000265	CcSEcCtD
Tiagabine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000264	CcSEcCtD
Tiagabine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000262	CcSEcCtD
Tiagabine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000195	0.000259	CcSEcCtD
Tiagabine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000259	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000257	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000256	CcSEcCtD
Tiagabine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000255	CcSEcCtD
Tiagabine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000255	CcSEcCtD
Tiagabine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000255	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000255	CcSEcCtD
Tiagabine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000254	CcSEcCtD
Tiagabine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000252	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.00025	CcSEcCtD
Tiagabine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00025	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000249	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000249	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000248	CcSEcCtD
Tiagabine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000247	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000245	CcSEcCtD
Tiagabine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000245	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000244	CcSEcCtD
Tiagabine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000243	CcSEcCtD
Tiagabine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000242	CcSEcCtD
Tiagabine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000241	CcSEcCtD
Tiagabine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.00024	CcSEcCtD
Tiagabine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00024	CcSEcCtD
Tiagabine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000239	CcSEcCtD
Tiagabine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000237	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000236	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000236	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000236	CcSEcCtD
Tiagabine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000235	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000233	CcSEcCtD
Tiagabine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000233	CcSEcCtD
Tiagabine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000231	CcSEcCtD
Tiagabine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000229	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000228	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000226	CcSEcCtD
Tiagabine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000225	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000223	CcSEcCtD
Tiagabine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000223	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000222	CcSEcCtD
Tiagabine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000221	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000221	CcSEcCtD
Tiagabine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00022	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000219	CcSEcCtD
Tiagabine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000218	CcSEcCtD
Tiagabine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000218	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000216	CcSEcCtD
Tiagabine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000215	CcSEcCtD
Tiagabine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000213	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000212	CcSEcCtD
Tiagabine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000211	CcSEcCtD
Tiagabine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000209	CcSEcCtD
Tiagabine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000209	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000206	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000205	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000203	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000202	CcSEcCtD
Tiagabine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000202	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000201	CcSEcCtD
Tiagabine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000151	0.0002	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000199	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000197	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000195	CcSEcCtD
Tiagabine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000194	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000194	CcSEcCtD
Tiagabine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000194	CcSEcCtD
Tiagabine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000193	CcSEcCtD
Tiagabine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000193	CcSEcCtD
Tiagabine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000187	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000185	CcSEcCtD
Tiagabine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00018	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00018	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000179	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000179	CcSEcCtD
Tiagabine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000176	CcSEcCtD
Tiagabine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000173	CcSEcCtD
Tiagabine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000167	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000167	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000162	CcSEcCtD
Tiagabine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000162	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00016	CcSEcCtD
Tiagabine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000156	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000155	CcSEcCtD
Tiagabine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000154	CcSEcCtD
Tiagabine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000154	CcSEcCtD
Tiagabine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000153	CcSEcCtD
Tiagabine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00015	CcSEcCtD
Tiagabine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000145	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000144	CcSEcCtD
Tiagabine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000143	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000143	CcSEcCtD
Tiagabine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000142	CcSEcCtD
Tiagabine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000134	CcSEcCtD
